-
Optimization of sample pretreatment methods for simultaneous determination of dolasetron and hydrodolasetron in human plasma by HPLC-ESI-MS.
Journal of chromatographic science 20121001
-
Comparative clinical effectiveness of various 5-HT3 RA antiemetic regimens on chemotherapy-induced nausea and vomiting associated with hospital and emergency department visits in real world practice.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120501
-
Efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.
Korean journal of anesthesiology 20120301
-
A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis.
Clinical therapeutics 20120201
-
A practical and direct comparison of intrinsic metabolic clearance of several non-CYP enzyme substrates in freshly isolated and cryopreserved hepatocytes.
Drug metabolism and pharmacokinetics 20120101
-
Reduction in the incidence of shivering with perioperative dexmedetomidine: A randomized prospective study.
Journal of anaesthesiology, clinical pharmacology 20120101
-
Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy.
Cancer management and research 20120101
-
Cardiovascular events in cancer patients treated with highly or moderately emetogenic chemotherapy: results from a population-based study.
Journal of cancer epidemiology 20120101
-
Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study.
BMC health services research 20120101
-
Management of postoperative nausea and vomiting in women scheduled for breast cancer surgery.
Journal of anesthesia 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111001
-
Retraction note to: Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20110901
-
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801
-
Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110601
-
Placebo-controlled comparison of dolasetron and metoclopramide in preventing postoperative nausea and vomiting in patients undergoing hysterectomy: Retraction.
European journal of anaesthesiology 20110601
-
5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities.
Journal of clinical anesthesia 20110601
-
Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results.
The Korean journal of hepatology 20110601
-
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia.
European journal of pain (London, England) 20110501
-
Dolasetron for preventing postanesthetic shivering: Retraction.
Anesthesia and analgesia 20110501
-
Retraction Notice: Current review of ramosetron in the prevention of postoperative nausea and vomiting.
Current drug safety 20110401
-
Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.
Cancer chemotherapy and pharmacology 20110301
-
Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Surgical endoscopy 20110301
-
Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.
International journal of clinical pharmacy 20110201
-
Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma.
Core evidence 20110101
-
BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs.
BMC bioinformatics 20110101
-
Genetic polymorphisms in the three malaysian races effect granisetron clinical antiemetic actions in breast cancer patients receiving chemotherapy.
Asian Pacific journal of cancer prevention : APJCP 20110101
-
Short term non-invasive ventilation post-surgery improves arterial blood-gases in obese subjects compared to supplemental oxygen delivery - a randomized controlled trial.
BMC anesthesiology 20110101
-
Palonosetron: A novel approach to control postoperative nausea and vomiting in day care surgery.
Saudi journal of anaesthesia 20110101
-
Symptomatic sinus bradycardia: A rare adverse effect of intravenous ondansetron.
Saudi journal of anaesthesia 20110101
-
Comparison of ondansetron and combination of ondansetron and dexamethasone as a prophylaxis for postoperative nausea and vomiting in adults undergoing elective laparoscopic surgery.
Journal of emergencies, trauma, and shock 20110101
-
Prophylaxis of postoperative nausea and vomiting in adolescent patients: a review with emphasis on combination of fixed-dose ondansetron and transdermal scopolamine.
Journal of drug delivery 20110101
-
Treating nausea and vomiting in palliative care: a review.
Clinical interventions in aging 20110101
-
Current concepts in the management of postoperative nausea and vomiting.
Anesthesiology research and practice 20110101
-
Prophylactic antiemetic effects in gynecologic patients receiving fentanyl IV-patient controlled analgesia: comparison of combined treatment with ondansetron and dexamethasone with metoclopramide and dexamethasone.
Korean journal of anesthesiology 20101101
-
Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat.
Brain research 20100917
-
Retraction Notice: Clinical Management of Postoperative Vomiting after Strabismus Surgery in Children.
Current drug safety 20100401
-
Comparison of perioperative oral multimodal analgesia versus IV PCA for spine surgery.
Journal of spinal disorders & techniques 20100401
-
Acute vomiting in cats: rational treatment selection.
Journal of feline medicine and surgery 20100301
-
Effect of ramosetron on shivering during spinal anesthesia.
Korean journal of anesthesiology 20100301
-
Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines.
Paediatric drugs 20100101
-
Other drugs acting on nervous system associated with QT-interval prolongation.
Current drug safety 20100101
-
Safety and effectiveness of outpatient laparoscopic cholecystectomy in a teaching hospital: a prospective study of 110 consecutive patients.
BMC research notes 20100101
-
Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review.
PloS one 20100101
-
A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
American journal of therapeutics 20100101
-
Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.
Cancer management and research 20100101
-
Acute gastroenteritis: from guidelines to real life.
Clinical and experimental gastroenterology 20100101
-
Palonosetron: in the prevention of nausea and vomiting.
Drugs 20091112
-
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090901
-
Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090901
-
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.
Current cardiology reviews 20090801
-
Prophylactic granisetron vs pethidine for the prevention of postoperative shivering: a randomized control trial.
Indian journal of anaesthesia 20090601
-
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.
Journal of clinical medicine research 20090601
-
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
The Lancet. Oncology 20090201
-
Retraction Notice: Current Management of Vomiting after Tonsillectomy in Children.
Current drug safety 20090101
-
Management of postoperative nausea and vomiting: focus on palonosetron.
Therapeutics and clinical risk management 20090101
-
Bilateral infraorbital nerve blocks decrease postoperative pain but do not reduce time to discharge following outpatient nasal surgery.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20090101
-
Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting.
Therapeutics and clinical risk management 20090101
-
Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron.
Cancer management and research 20090101
-
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy.
Cancer management and research 20090101
-
Dolasetron and QT interval.
Emergency medicine journal : EMJ 20081001
-
The acute effect of tropisetron on ECG parameters in cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080901
-
Fatal metformin overdose presenting with progressive hyperglycemia.
The western journal of emergency medicine 20080801
-
Ondansetron induced fatal ventricular tachycardia.
Indian journal of pharmacology 20080801
-
Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20080401
-
Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20080401
-
Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report.
AANA journal 20080201
-
Chemotherapy-and cancer-related nausea and vomiting.
Current oncology (Toronto, Ont.) 20080101
-
[Pharmacokinetic and pharmacodynamic features of palonosetron].
Tumori 20080101
-
[Meta-analysis of phase III studies with palonosetron in the prevention of vomiting induced by moderately emetogenic chemotherapy].
Tumori 20080101
-
[Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects].
Tumori 20080101
-
Retraction Notice: The Benefits and Risks of Different Therapies in Preventing Postoperative Nausea and Vomiting in Patients Undergoing Thyroid Surgery.
Current drug safety 20080101
-
Mining clinical relationships from patient narratives.
BMC bioinformatics 20080101
-
Dolasetron-induced torsades de pointes.
Journal of clinical anesthesia 20071201
-
Palonosetron as an anti-emetic and anti-nausea agent in oncology.
Therapeutics and clinical risk management 20071201
-
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070901
-
[Prevention of postoperative nausea and vomiting].
Ugeskrift for laeger 20070813
-
The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting.
Anaesthesia 20070801
-
Ondansetron oral disintegrating tablets for the prevention of postoperative vomiting in children undergoing strabismus surgery.
Therapeutics and clinical risk management 20070801
-
Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review.
Emergency medicine journal : EMJ 20070701
-
Antiemetic agents.
Oncology (Williston Park, N.Y.) 20070701
-
[Prevention and treatment of postoperative nausea and vomiting in children. An evidence-based approach].
Annales francaises d'anesthesie et de reanimation 20070601
-
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20070601
-
Randomized comparison of two anti-emetic strategies in high-risk patients undergoing day-case gynaecological surgery.
British journal of anaesthesia 20070401
-
Management of radiation-induced nausea and vomiting.
Experimental hematology 20070401
-
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Pediatric blood & cancer 20070301
-
Tremor in multiple sclerosis.
Journal of neurology 20070201
-
[Dolasetron and shivering. A prospective randomized placebo-controlled pharmaco-economic evaluation].
Der Anaesthesist 20070101
-
Are all 5-HT3 receptor antagonists the same?
Journal of the National Comprehensive Cancer Network : JNCCN 20070101
-
Management of postoperative nausea and vomiting in children.
Paediatric drugs 20070101
-
Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101
-
Acute gastroenteritis in children: role of anti-emetic medication for gastroenteritis-related vomiting.
Paediatric drugs 20070101
-
Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials.
BMC cancer 20070101
-
Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting.
Core evidence 20070101
-
Pharmacological prophylaxis and management of adult postoperative/postdischarge nausea and vomiting.
Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses 20061201
-
Inspired oxygen fraction of 0.8 compared with 0.4 does not further reduce postoperative nausea and vomiting in dolasetron-treated patients undergoing laparoscopic cholecystectomy.
British journal of anaesthesia 20061101
-
Prophylaxis of postoperative vomiting in children undergoing tonsillectomy: a systematic review and meta-analysis.
British journal of anaesthesia 20061101
-
Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.
Future oncology (London, England) 20061001
-
Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: a prospective, double-blind, randomized trial.
Military medicine 20060901
-
Ethics, marketing, and the medical literature.
Anesthesia and analgesia 20060801
-
Drugs for preventing postoperative nausea and vomiting.
The Cochrane database of systematic reviews 20060719
-
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
Journal of clinical pharmacology 20060701
-
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20060601
-
Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV.
The Annals of pharmacotherapy 20060501
-
Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies.
The Annals of pharmacotherapy 20060501
-
Paravertebral blocks provide superior same-day recovery over general anesthesia for patients undergoing inguinal hernia repair.
Anesthesia and analgesia 20060401
-
Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype.
Anesthesia and analgesia 20060401
-
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
Supportive cancer therapy 20060401
-
Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics.
Drug metabolism and disposition: the biological fate of chemicals 20060301
-
New antiemetic drugs.
Annals of oncology : official journal of the European Society for Medical Oncology 20060301
-
Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
The journal of supportive oncology 20060101
-
The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
AORN journal 20060101
-
Laparoscopic cholecystectomy and management of biliary tract stones in a freestanding ambulatory surgery center.
JSLS : Journal of the Society of Laparoendoscopic Surgeons 20060101
-
Anesthesiologists' practice patterns for treatment of postoperative nausea and vomiting in the ambulatory Post Anesthesia Care Unit.
BMC anesthesiology 20060101
-
New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations.
Cancer journal (Sudbury, Mass.) 20060101
-
Prophylaxis of postoperative nausea and vomiting in patients scheduled for breast surgery.
Clinical drug investigation 20060101
-
Systematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room - implications for the treatment of PONV and related clinical trials.
BMC anesthesiology 20060101
-
Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest?
Anesthesia and analgesia 20051201
-
Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting.
The Annals of pharmacotherapy 20051101
-
Prophylactic intravenous ondansetron and dolasetron in intrathecal morphine-induced pruritus: a randomized, double-blinded, placebo-controlled study.
Anesthesia and analgesia 20051101
-
Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
Medical science monitor : international medical journal of experimental and clinical research 20051001
-
Dolasetron and peri-operative cardiac arrhythmia.
Anaesthesia 20050901
-
Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors.
Anesthesia and analgesia 20050901
-
5HT3-receptor antagonists as antiemetics in cancer.
Drug and therapeutics bulletin 20050801
-
Update on anti-emetics for chemotherapy-induced emesis.
Internal medicine journal 20050801
-
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
Cancer 20050701
-
Prevention and treatment of postoperative nausea and vomiting.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050615
-
Prediction of genotoxicity of chemical compounds by statistical learning methods.
Chemical research in toxicology 20050601
-
Pharmacokinetics of palonosetron in combination with aprepitant in healthy volunteers.
Current medical research and opinion 20050401
-
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer.
British journal of cancer 20050314
-
Acute emesis: moderately emetogenic chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20050201
-
Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
Anesthesia and analgesia 20050201
-
Coronary vasospasm leading to an acute myocardial infarction after the administration of dolasetron.
Journal of clinical anesthesia 20050201
-
Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?
CNS drugs 20050101
-
The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy.
Current pharmaceutical design 20050101
-
The Breast Journal regrettably is retracting a manuscript entitled, ' Dolasetron decreases postoperative nausea and vomiting after breast surgery'.
The breast journal 20050101
-
A randomized, multicenter, open-label comparison of the antiemetic efficacy of dolasetron versus ondansetron for the prevention of nausea and vomiting during high-dose myeloablative chemotherapy.
Supportive cancer therapy 20050101
-
Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol.
The Journal of pharmacy and pharmacology 20041201
-
Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients.
Cancer research and treatment : official journal of Korean Cancer Association 20041201
-
5-HT3 receptor antagonists for prevention of late acute-onset emesis.
The Annals of pharmacotherapy 20041001
-
Single-dose parenteral pharmacological interventions for the prevention of postoperative shivering: a quantitative systematic review of randomized controlled trials.
Anesthesia and analgesia 20040901
-
Droperidol and dolasetron alone or in combination for prevention of postoperative nausea and vomiting after vitrectomy.
Ophthalmology 20040801
-
Timing of administration of dolasetron affects dose necessary to prevent postoperative nausea and vomiting.
Journal of clinical anesthesia 20040801
-
A comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries.
Anesthesiology 20040701
-
Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
Current medical research and opinion 20040601
-
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Clinical advances in hematology & oncology : H&O 20040501
-
Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results.
British journal of cancer 20040405
-
Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures.
AANA journal 20040401
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20040101
-
Palonosetron.
Drugs 20040101
-
Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?
BMC surgery 20040101
-
Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemetics.
Drugs & aging 20040101
-
Spectrum of use and tolerability of 5-HT3 receptor antagonists.
Scandinavian journal of rheumatology. Supplement 20040101
-
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.
Cancer 20031201
-
Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis.
Expert opinion on pharmacotherapy 20031201
-
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
British journal of cancer 20031117
-
Randomized, double-blind trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery.
Annals of plastic surgery 20031101
-
[Blocking nociceptive afferents by retrobulbar bupivacaine does not decrease nausea and vomiting after propofol-remifentanil anaesthesia].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20031101
-
Stability of dolasetron in two oral liquid vehicles.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031101
-
Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
European journal of anaesthesiology 20031001
-
Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis.
Journal of neurology 20031001
-
Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.
The Annals of pharmacotherapy 20030901
-
Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Expert opinion on pharmacotherapy 20030901
-
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Bioorganic & medicinal chemistry letters 20030818
-
A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery.
Anesthesia and analgesia 20030801
-
Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery.
Paediatric anaesthesia 20030701
-
Cost-effectiveness of antiemetics use during cancer chemotherapy.
Expert review of pharmacoeconomics & outcomes research 20030601
-
Patient outcomes after therapeutic interchange of dolasetron for granisetron.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030515
-
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20030301
-
Dolasetron prophylaxis reduces nausea and postanaesthesia recovery time after remifentanil infusion during monitored anaesthesia care for extracorporeal shock wave lithotripsy.
British journal of anaesthesia 20030201
-
Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
Anesthesiology 20030201
-
[Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
Der Anaesthesist 20030201
-
The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron.
Anaesthesia and intensive care 20030201
-
Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.
Drug safety 20030101
-
Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy.
Health and quality of life outcomes 20030101
-
Writers challenge points made in article about antiemetic therapy.
Oncology nursing forum 20030101
-
QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.
American journal of therapeutics 20030101
-
Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models.
Journal of receptor and signal transduction research 20030101
-
A systematic approach to the management of postoperative nausea and vomiting.
Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses 20021201
-
Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20021201
-
Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
Anesthesia and analgesia 20021101
-
Pharmacological prevention of postanesthetic shivering.
Anesthesia and analgesia 20021001
-
[Dolasetron reduces pain on injection of propofol].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20020901
-
Progress in preventing chemotherapy-induced nausea and vomiting.
Cleveland Clinic journal of medicine 20020801
-
Probable serotonin syndrome variant in a patient receiving a selective serotonin reuptake inhibitor and a 5-HT3 receptor antagonist.
Journal of psychopharmacology (Oxford, England) 20020601
-
Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy.
Anesthesiology 20020601
-
Granisetron vs ondansetron: is it a question of duration of 5-HT3 receptor blockade?
British journal of cancer 20020520
-
The effect of anaesthetic technique on postoperative nausea and vomiting after day-case gynaecological laparoscopy.
Anaesthesia and intensive care 20020401
-
Monocomponent chemoembolization in oral and oropharyngeal cancer using an aqueous crystal suspension of cisplatin.
British journal of cancer 20020121
-
Dolasetron for preventing postanesthetic shivering.
Anesthesia and analgesia 20020101
-
[Prophylaxis of Postoperative Nausea and Vomiting FollowingGynaecological Laparoscopy].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20020101
-
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?
The oncologist 20020101
-
Dolasetron decreases postoperative nausea and vomiting after breast surgery.
The breast journal 20020101
-
5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile.
The oncologist 20020101
-
5-HT3-receptor antagonists and the cytochrome P450 system: clinical implications.
Cancer journal (Sudbury, Mass.) 20020101
-
Compatibility and stability of 5-HT3 receptor antagonists: a pharmacology review.
Oncology nursing forum 20020101
-
Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20011101
-
The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting.
Anesthesia and analgesia 20011001
-
[Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20010701
-
Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting.
Clinical therapeutics 20010601
-
Placebo-controlled comparison of dolasetron and metoclopramide in preventing postoperative nausea and vomiting in patients undergoing hysterectomy.
European journal of anaesthesiology 20010401
-
Dolasetron for chemo nausea.
RN 20010301
-
Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101
-
5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Drugs 19980201
-
Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery.
Drugs 19970801
-
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 19970101